a month ago
TNYA
AnalystsJoseph PantginisJoseph Pantginis's Stock Forecasts
AnalystsJoseph Pantginis
Analyst Ranking
Bottom 1%
#4861 out of 4861 analysts
Average Return
-14.41%
Win Rate
26%223 out of 850
Risk vs Reward
Poor
Good
Joseph Pantginis's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Celldex Therapeutics IncCLDX | +1,183.78% | $1.85 | $23.75 | 2020-03-27 - 2021-03-26 | Buy |
Alpine Immune Sciences IncALPN | +694.86% | $8.17 | $64.94 | 2023-05-12 - 2024-05-10 | Buy |
Tempest Therapeutics IncTPST | +659.07% | $0.77 | $5.86 | 2025-03-28 - 2025-04-10 | Buy |
Biomea Fusion IncBMEA | +644.47% | $4.79 | $35.66 | 2022-06-02 - 2023-06-01 | Buy |
Tempest Therapeutics IncTPST | +506.00% | $0.97 | $5.86 | 2024-11-13 - 2025-04-10 | Buy |
Joseph Pantginis Analyst Color
Get additional color on Joseph Pantginis's coverage of popular stocks
5 months ago
BLRX
6 months ago
CAPR
a year ago
VKTX
Joseph Pantginis's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Viking Therapeutics IncVKTX | 30 | Buy | $102.00 | +326.07% | Reiterates | 4 days ago |
Cytokinetics IncCYTK | 43 | Buy | $120.00 | +203.95% | Reiterates | 6 days ago |
Gri Bio IncGRI | 2 | Buy | $10.00 | +562.25% | Reiterates | 8 days ago |
Tempest Therapeutics IncTPST | 19 | Hold | $16.00 | +119.78% | Downgrades | 12 days ago |
Clene IncCLNN | 29 | Buy | $31.00 | +933.33% | Reiterates | 13 days ago |
Biomx IncPHGE | 13 | Buy | $21.00 | +3,788.89% | Reiterates | 18 days ago |
Compass Therapeutics IncCMPX | 17 | Buy | $24.00 | +1,271.43% | Maintains | 18 days ago |
Kairos Pharma LtdKAPA | 1 | Buy | $12.00 | +1,150.00% | Initiates Coverage On | 19 days ago |
Biomea Fusion IncBMEA | 28 | Buy | $40.00 | +2,266.86% | Reiterates | 21 days ago |
Calcimedica IncCALC | 11 | Buy | $16.00 | +932.26% | Reiterates | 21 days ago |
Actinium Pharmaceuticals IncATNM | 27 | Buy | $4.00 | +230.58% | Reiterates | 21 days ago |
Biolinerx LtdBLRX | 11 | Buy | $26.00 | +802.78% | Maintains | 21 days ago |
Tenaya Therapeutics IncTNYA | 15 | Buy | $5.00 | +1,011.11% | Reiterates | 21 days ago |
Aptose Biosciences IncAPTOF | 15 | Buy | $6.00 | +250.88% | Maintains | 24 days ago |
Lexicon Pharmaceuticals IncLXRX | 21 | Buy | $4.00 | +684.31% | Reiterates | 24 days ago |
Xoma Royalty CorpXOMA | 23 | Buy | $104.00 | +391.03% | Reiterates | 25 days ago |
Pds Biotechnology CorpPDSB | 28 | Buy | $13.00 | +1,103.70% | Maintains | 25 days ago |
Pharming Group NvPHAR | 17 | Buy | $37.00 | +357.35% | Reiterates | a month ago |
Esperion Therapeutics IncESPR | 26 | Buy | $16.00 | +1,584.21% | Reiterates | a month ago |
Capricor Therapeutics IncCAPR | 20 | Buy | $77.00 | +584.44% | Reiterates | a month ago |
Omniab IncOABI | 7 | Buy | $11.00 | +514.53% | Reiterates | a month ago |
Fibrogen IncFGEN | 2 | Buy | $10.00 | +3,396.50% | Reiterates | a month ago |
Atyr Pharma IncATYR | 21 | Buy | $35.00 | +1,029.03% | Reiterates | a month ago |
Astria Therapeutics IncATXS | 20 | Buy | $16.00 | +296.04% | Reiterates | a month ago |
Checkpoint Therapeutics IncCKPT | 17 | Hold | $4.10 | +1.49% | Downgrades | a month ago |
Lineage Cell Therapeutics IncLCTX | 11 | Buy | $9.00 | +2,095.12% | Reiterates | a month ago |
Vyne Therapeutics IncVYNE | 19 | Buy | $5.75 | +210.81% | Reiterates | 2 months ago |
Rigel Pharmaceuticals IncRIGL | 22 | Buy | $57.00 | +238.28% | Reiterates | 2 months ago |
Celldex Therapeutics IncCLDX | 30 | Buy | $80.00 | +337.16% | Reiterates | 2 months ago |
Krystal Biotech IncKRYS | 25 | Buy | $221.00 | +31.10% | Reiterates | 2 months ago |
Iovance Biotherapeutics IncIOVA | 24 | Buy | $32.00 | +945.75% | Reiterates | 2 months ago |
Kura Oncology IncKURA | 20 | Buy | $40.00 | +577.97% | Reiterates | 2 months ago |
Nuvectis Pharma IncNVCT | 7 | Buy | $11.00 | +24.08% | Maintains | 2 months ago |
Palatin Technologies IncPTN | 27 | Buy | $7.00 | +4,142.42% | Maintains | 2 months ago |
Neuphoria Therapeutics IncNEUP | 7 | Buy | $21.00 | +308.64% | Maintains | 3 months ago |
Aprea Therapeutics IncAPRE | 14 | Buy | $20.00 | +1,233.33% | Reiterates | 3 months ago |
Armata Pharmaceuticals IncARMP | 14 | Buy | $7.00 | +469.11% | Reiterates | 4 months ago |
Biocardia IncBCDA | 15 | Buy | $25.00 | +1,202.08% | Reiterates | 4 months ago |
Lisata Therapeutics IncLSTA | 17 | Buy | $15.00 | +564.89% | Reiterates | 4 months ago |
Fortress Biotech IncFBIO | 2 | Buy | $26.00 | +1,599.35% | Maintains | 5 months ago |
Adlai Nortye LtdANL | 3 | Buy | $9.00 | +426.32% | Reiterates | 5 months ago |
Ligand Pharmaceuticals IncLGND | 18 | Buy | $157.00 | +49.57% | Reiterates | 5 months ago |
Genenta Science SpaGNTA | 4 | Buy | $25.00 | +544.33% | Reiterates | 7 months ago |
Shattuck Labs IncSTTK | 15 | Buy | $16.00 | +1,969.86% | Reiterates | 8 months ago |
Biora Therapeutics IncBIOR | 9 | Buy | $150.00 | +26,685.71% | Reiterates | 8 months ago |
Cadrenal Therapeutics IncCVKD | 4 | Buy | $45.00 | +168.66% | Reiterates | a year ago |
Mustang Bio IncMBIO | 6 | Buy | $100.00 | +7,418.80% | Reiterates | a year ago |
Panbela Therapeutics IncPBLA | 8 | Buy | $5.00 | N/A | Maintains | a year ago |
Alpine Immune Sciences IncALPN | 7 | Buy | $50.00 | N/A | Maintains | a year ago |
Traws Pharma IncTRAW | 9 | Buy | $11.00 | N/A | Reiterates | 2 years ago |
Biophytis SaBPTSY | 5 | Buy | $600.00 | N/A | Reiterates | 2 years ago |
Decibel Therapeutics IncDBTX | 5 | Buy | $23.00 | N/A | Reiterates | 2 years ago |
Atreca IncBCEL | 5 | Buy | $25.00 | N/A | Reiterates | 2 years ago |
Aravive IncARAV | 9 | Buy | $12.00 | N/A | Reiterates | 2 years ago |
Xenetic Biosciences IncXBIO | 3 | Buy | $40.00 | N/A | Reiterates | 2 years ago |
IMV IncIMVIQ | 1 | Buy | $65.00 | N/A | Reiterates | 2 years ago |
Applied Genetic Technologies CorpAGTC | 3 | Hold | N/A | N/A | Downgrades | 2 years ago |
Akouos IncAKUS | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Humanigen IncHGENQ | 3 | Hold | N/A | N/A | Downgrades | 3 years ago |
Genocea Biosciences IncGNCAQ | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Sierra Oncology IncSRRA | 1 | Hold | $55.00 | N/A | Downgrades | 3 years ago |
Sio Gene Therapies IncSIOX | 3 | Buy | $7.00 | N/A | Maintains | 3 years ago |
Beyondspring IncBYSI | 4 | Hold | N/A | N/A | Downgrades | 3 years ago |
Essa Pharma IncEPIX | 3 | Buy | $32.00 | N/A | Maintains | 4 years ago |
Strata Skin Sciences IncSSKN | 1 | Buy | $30.00 | N/A | Upgrades | 4 years ago |
Principia Biopharma IncPRNB | 4 | Hold | $100.00 | N/A | Downgrades | 5 years ago |
Avid Bioservices IncCDMO | 2 | Buy | $9.00 | N/A | Reiterates | 5 years ago |
Immune Design CorpIMDZ | 1 | Buy | $7.75 | N/A | Maintains | 7 years ago |
Tg Therapeutics IncTGTX | 2 | Buy | $33.00 | N/A | Assumes | 7 years ago |
Soligenix IncSNGX | 1 | Buy | $2,640.00 | N/A | Initiates Coverage On | 8 years ago |
Palvella Therapeutics IncPVLA | 1 | Strong Buy | $720.00 | N/A | Initiates Coverage On | 8 years ago |
Verastem IncVSTM | 1 | Buy | $78.00 | N/A | Reiterates | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.